BWM
ANIP icon

BerganKDV Wealth Management’s ANI Pharmaceuticals ANIP Stock Holding History

BerganKDV Wealth Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,000
Closed -$141K – 729
2019
Q1 		$141K Buy
+2,000
New +$118K 0.03% 238

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

BerganKDV Wealth Management's ANIP Position: Q2 2019 in Review

BerganKDV Wealth Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2019, closing a stake of 2,000 shares — an estimated $141K sold.

BerganKDV Wealth Management first reported a position in ANIP in Q1 2019 and held it in 1 quarter. The position peaked at $141K in Q1 2019. 196 funds tracked by Wall St. Rank hold ANIP as of Q2 2019.

  • BerganKDV Wealth Management reported no remaining ANI Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • BerganKDV Wealth Management sold 2,000 ANI Pharmaceuticals shares in Q2 2019, an estimated $141K.
  • BerganKDV Wealth Management first reported a position in ANI Pharmaceuticals in Q1 2019 and held it in 1 quarter.
  • BerganKDV Wealth Management's ANI Pharmaceuticals position peaked at $141K in Q1 2019.
  • 196 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2019.

Based on BerganKDV Wealth Management's 13F filing for Q2 2019, filed 12 Aug 2019.